New Way Now: How Google AI put Medable on track to cut drug development time from 12 years to one

*Featured in this video:* Dr. Michelle Longmire, CEO and Co-founder, Medable *Executive summary:* Drug development typically takes 12 years with humans completing complex scientific milestones manually, which means clinical trials often struggle with slow patient enrollment and site startup that takes months or years. Medable provides technology that accelerates clinical development by removing critical bottlenecks across over 1 million patients in 120+ languages and 60 countries. Using Google Cloud infrastructure, Vertex AI Agent Builder (which has evolved into Gemini Enterprise Agent Platform), Gemini, BigQuery, and Security Command Center, Medable has compressed timelines with agentic AI while achieving 90% patient adherence. Medable’s “1:1:1” vision aims to compress drug development to one year with one-day patient enrollment and one- day site startup. *Challenge:* The development of a single medicine is approximately a 12-year process involving complex scientific milestones in human testing and clinical trials. This is mostly completed by unassisted humans, creating significant burnout and delays. Medable saw an opportunity to alleviate these pressures by automating key moments in the clinical trial process with agentic AI. However, while pharmaceutical companies are deep technical experts in clinical development, they are not computer scientists, so they need no-code solutions to deploy agentic AI effectively. Additionally, translating scientific protocols into language that resonates with patients across 120+ languages and 60 countries while maintaining high adherence rates presents a challenge for global clinical trials. *Solution:* Medable runs on Google Cloud, and with Gemini and Vertex AI offers no-code agentic AI solutions that pharma companies can deploy quickly and with confidence. BigQuery provides real-time analytics, operating globally 24/7 to store operational data across studies, while Google Cloud Security Command Center ensures top-priority security for patients, doctors, clinics, and pharmaceutical companies. Meanwhile, Gemini speeds translations prior to signoff so that trials get off the ground quicker. Medable envisions agentic AI facilitating every milestone of clinical development, with humans providing strategic leverage and AI handling the tactical work that leads to burnout. *Result:* The Medable platform supports participants and caregivers across 120+ languages in 60 countries with 90%+ patient adherence. This agentic AI-based system has already compressed clinical trial timelines by starting sites sooner, finding patients faster, and retaining patients better. By making clinical development faster and less expensive for pharma, smoother for participating patients, and easier for clinical sites, Medable is working toward its ambitious goal to increase drug approvals from approximately 50 per year to 500, ultimately enabling effective therapies to reach patients exponentially faster. *Highlights and key takeaways from our interview with Dr. Michelle Longmire, CEO and Co-founder of Medable:* → “The combination of Medable and Google enables a no-code solution that pharma companies can get going and deploy powerful agentic solutions into development from day one.” → “Security is a top priority. Patients, doctors, clinics, and pharmaceutical companies rely on Medable every day, and we rely on Google Cloud Security Command Center to have that assurance that we’re providing the very best technology for security to our ecosystem of users.” *Google Cloud products used:* BigQuery, Gemini, Security Command Center, Vertex AI Agent Builder (which has evolved into Agent Platform) *Learn more:* → https://www.medable.com/